These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36992247)

  • 1. Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
    Tohme RA; Scobie HM; Okunromade O; Olaleye T; Shuaib F; Jegede T; Yahaya R; Nnaemeka N; Lawal B; Egwuenu A; Parameswaran N; Cooley G; An Q; Coughlin M; Okposen BB; Adetifa I; Bolu O; Ihekweazu C
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
    PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.
    Cheng A; Ghanem-Uzqueda A; Hoff NA; Ashbaugh H; Doshi RH; Mukadi P; Budd R; Higgins SG; Randall C; Gerber S; Kabamba M; Ngoie Mwamba G; Okitolonda-Wemakoy E; Muyembe-Tanfum JJ; Rimoin AW
    PLoS One; 2022; 17(5):e0268703. PubMed ID: 35587922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low seroprotection against diphtheria and tetanus in Lao adolescents.
    Vantava S; Hefele L; Virachith S; Vannachone S; Khounvisith V; Nouanthong P; Hübschen JM; Sayasone S; Black AP
    Trop Med Int Health; 2023 Jun; 28(6):501-506. PubMed ID: 37199458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
    Minta AA; Andre-Alboth J; Childs L; Nace D; Rey-Benito G; Boncy J; Adrien P; Francois J; Phaïmyr Jn Charles N; Blot V; Vanden Eng J; Priest JW; Rogier E; Tohme RA
    Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.
    Boey L; Bosmans E; Ferreira LB; Heyvaert N; Nelen M; Smans L; Tuerlinckx H; Roelants M; Claes K; Derdelinckx I; Janssens W; Mathieu C; Van Cleemput J; Vos R; Desombere I; Vandermeulen C
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33406698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
    Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
    Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
    Khetsuriani N; Zaika O; Slobodianyk L; Scobie HM; Cooley G; Dimitrova SD; Stewart B; Geleishvili M; Allahverdiyeva V; O'Connor P; Huseynov S
    Vaccine; 2022 Mar; 40(12):1810-1820. PubMed ID: 35153095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand.
    Suntarattiwong P; Vandepitte WP; Singhamatr P; Chotpitayasunondh T
    Vaccine; 2020 Feb; 38(9):2128-2131. PubMed ID: 31987691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults.
    Petráš M; Oleár V; Molitorisová M; Dáňová J; Čelko AM; Nováková E; Štefkovičová M; Krištúfková Z; Malinová J; Lesná IK
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31591336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
    Mullaert J; Abgrall S; Lele N; Batteux F; Slama LB; Meritet JF; Lebon P; Bouchaud O; Grabar S; Launay O;
    Vaccine; 2015 Sep; 33(38):4938-44. PubMed ID: 26209841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
    Škovránková J; Petráš M
    Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group.
    Stojanov S; Liese JG; Bendjenana H; Harzer E; Barrand M; Jow S; Dupuy M; Belohradsky BH
    Pediatr Infect Dis J; 2000 Jun; 19(6):516-21. PubMed ID: 10877165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.
    Scott LJ
    Paediatr Drugs; 2011 Apr; 13(2):133-5. PubMed ID: 21351814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprotection for Diphtheria, Pertussis, Tetanus and Measles in Children With Nephrotic Syndrome.
    Ajay M; Mantan M; Dabas A; Asraf A; Yadav S; Chakravarti A
    Indian Pediatr; 2021 Mar; 58(3):233-236. PubMed ID: 33713058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.